Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Field-Programmable Gate Array-Based Ultra-Low Power Discrete Fourier Transforms for Closed-Loop Neural Sensing.
Journal: bioRxiv : the preprint server for biology
Published: February 24, 2025
Geriatric Oncology Workshop (GrOW): Development and Evaluation of a Nationwide Nursing Curriculum.
Journal: Journal of geriatric oncology
Published: January 24, 2020
Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2019
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.
Journal: Cancer immunology, immunotherapy : CII
Published: May 10, 2018
Improving bone marrow biopsy quality through peer discussion and data comparisons: A single institution experience.
Journal: International journal of laboratory hematology
Published: December 18, 2017
Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 06, 2012
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival.
Journal: Cancer immunology, immunotherapy : CII
Published: October 15, 2012
Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: July 31, 2012
Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects.
Journal: Cancer immunology, immunotherapy : CII
Published: November 09, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026